3.25.19 |
Griffith, Ybarra Join SWHR Board of Directors
SWHR announced the election of two new members to its Board of Directors: Dr. Linda G. Griffith and Dr. Michael Ybarra.
3.11.19 | Sleep
Struggling to ‘Spring Forward’? Rethink Your Sleep Routine
Science is telling us more clearly all the time that we are setting ourselves up for failure by ignoring sleep as a critical part of the equation for good health.
3.4.19 | HPV
The HPV Vaccine: A Step Forward for Women’s Health
The HPV vaccine is one of the major milestones in cancer research, displaying the great promise of cancer prevention.
2.27.19 | Maternal Health
Pregnancy Complications May Influence Women’s Future Heart Health
A growing body of evidence shows women may have an increased risk of heart disease in the decades following a pregnancy in which they suffered from complications such as gestational diabetes or preeclampsia.
2.25.19 | Endometriosis
Identifying Barriers to Care for Women With Endometriosis
An SWHR working group published an expert review that identifies areas of need to improve a woman’s diagnosis, treatment, and access to quality care, as well as highlights priorities for the future of endometriosis research and care.
1.22.19 | Maternal Health
New Treatments, Universal Screening May Ease Burden of Perinatal Depression
The most common, most underdiagnosed, and most undertreated pregnancy-related complication in the United States is perinatal depression — depression that occurs during pregnancy or within the first year after delivery. An estimated 10 to 20 percent of new mothers experience perinatal depression (a more inclusive term than postpartum depression), with half of these women going undiagnosed and untreated.
1.14.19 | Policy
SWHR Engages With FDA on Patient-Focused Drug Development
SWHR seeks to ensure that meaningful input from women is included in the development and regulatory review of new medical products.
12.20.18 | Policy
Roche Diagnostics CMO Alan Wright Joins SWHR Board of Directors
The Society for Women’s Health Research (SWHR) is pleased to announced the election of Alan Wright, MD, MPH, chief medical officer at Roche Diagnostics Corp., to its Board of Directors.
12.6.18 | Policy
SWHR Praises Work of Dedicated FDA Women’s Health Advocate Marsha Henderson
In her 22 years at the Food and Drug Administration, Marsha B. Henderson has had a profound influence on the advancement of women’s health research. When she retires at the end of this year, the FDA will surely feel the absence of this dedicated advocate and her leadership as FDA’s associate commissioner for women’s health and director of the Office of Women’s Health (OWH).
11.26.18 | Urology
Survey of School Nurses Reveals Lack of Bathroom Policies and Bladder Health Education
In an online survey developed by SWHR, a majority of school nurses reported that the pre-K-12 schools they work for do not have written policies on student bathroom use and do not have education for students and teachers on bladder health.
